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The type III secretion system (T3SS) is Shigella’s most important virulence factor. The
T3SS apparatus (T3SA) is comprised of an envelope-spanning basal body and an
external needle topped by a tip complex protein called IpaD. This nanomachine is used
to deliver effector proteins into host cells to promote pathogen entry. A key component
of the matured T3SS needle tip complex is the translocator protein IpaB. IpaB can exist
in multiple states when prepared as a recombinant protein, however, it has also been
described as having additional roles in Shigella pathogenesis. This mini-review will briefly
describe some of the features of IpaB as a T3SS needle tip protein, as a pore-forming
translocator protein and as an effector protein. Reflection on the potential importance of
the different in vitro states of IpaB on its function and importance in serotype-independent
vaccines is also provided.
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INTRODUCTION
Shigella
Shigella species (S. flexneri, S. dysenteriae, S. sonnei, and S. boydii) are etiologic agents of shigellosis,
a potentially life-threatening bacillary dysentery. While shigellosis is recognized as a disease of
the developing world (Sansonetti, 2006; Kotloff et al., 2013), it is also an underreported problem
in industrialized regions where outbreaks are not uncommon (Sjölund Karlsson et al., 2013;
Thompson et al., 2015). Following ingestion of contaminated water, Shigella travels to the colon
where it invades the intestinal epithelium (Adam and Picking, 2015). Infection is initiated when
Shigella crossesM cells and invades/kills resident macrophages in the associated lymphoid tissues
(Zychlinsky et al., 1992). This provides the bacterium with access to the basal side of the colonic
epithelium. From here Shigella invades the overlying epithelial cells by macropinocytosis followed
by vacuolar escape into the host cytoplasmwhere it replicates and directly invades neighboring cells
(Carayol and Tran Van Nhieu, 2013; Tran Van Nhieu and Sansonetti, 2015). Shigella’s ability to kill
macrophages and invade epithelial cells is key to its virulence.
The Gram Negative Bacterial Type III Secretion System (T3SS)
Many Gram negative pathogens possess type III secretion systems (T3SS; Burkinshaw and
Strynadka, 2014; Portaliou et al., 2015). The T3SS allows communication with eukaryotic
cells to subvert normal cellular processes for the pathogen’s benefit. The T3SS apparatus
(T3SA) is a complex nanomachine used to deliver bacterial effector proteins directly into
and across eukaryotic cell membranes. The architecture of the T3SA is well conserved
among otherwise diverse bacteria. In contrast, the effector proteins that are responsible
for subverting host cell activities are pathogen specific with regard to their functions and
roles in pathogenesis (Bulgin et al., 2010; Plano and Schesser, 2013; Raymond et al., 2013).
Three of the best characterized T3SA structures belong to Shigella, Salmonella and Yersinia
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(Kubori et al., 1998; Mueller et al., 2005; Kawamoto et al., 2013;
Hu et al., 2015).Among these, the T3SA of Shigella and that
encoded by the Salmonella Pathogenicity Island 1 (SPI-1) are
the most closely related with respect to overall structure and the
structure of the controlling needle tip complex that is described
below.
A Brief Overview of the Shigella T3SA
Structure
Much of what is known of the T3SA structure stems from
transmission electron microscopy studies of S. flexneri and
Salmonella Typhimurium (Kubori et al., 1998; Blocker et al.,
1999; Tamano et al., 2000; Sani et al., 2007; Veenendaal et al.,
2007; Lara-Tejero et al., 2011). The overall T3SA architecture
resembles a syringe and needle that creates a conduit from
the bacterium to the host cell interior (Figure 1). The T3SA is
composed of over 25 different protein with many dedicated to
forming the basal body which spans the bacterial envelope. This
structure possesses a cytoplasmic bulb or sorting platform (see
Figure 1) that controls the hierarchy of secretion needed for
apparatus assembly and the controlled release of effectors (Lara-
Tejero et al., 2011; Hu et al., 2015). In Shigella, the ATPase Spa47
(similar to the β subunit of the F0F1 ATPases) provides a portion
of the catalytic power of the T3SS (Johnson and Blocker, 2008)
and is involved in separating effector proteins from their cognate
chaperones within the soring platform prior to effector secretion
(Lara-Tejero et al., 2011). The remaining structural components
of the injectisome basal body consist of: (a) rings imbedded in
the cytoplasmic membrane; (b) inner rod proteins that span the
periplasm; and (c) outermembrane ring proteins that connect the
base with the extracellular portions of the T3SA (Figure 1). There
are reviews available that describe the detailed structural and
functional roles of the basal body components (e.g., Burkinshaw
and Strynadka, 2014; Portaliou et al., 2015).
Extending outward from the T3SA base is a needle that crosses
the outer membrane with an exposed tip complex (TC; Kenjale
et al., 2005; Picking et al., 2005; Deane et al., 2006; Espina et al.,
2006; Olive et al., 2007; Epler et al., 2012; Fujii et al., 2012). The
TC is exposed to the extracellular environment where it has a
role in sensing the signals that lead to secretion induction (i.e.,
host cell contact). The Shigella needle is ∼45 to 50 nm in length,
with an outer diameter of 7 nm and a 2–3 nm wide inner channel
(Deane et al., 2006; Shen et al., 2012). Based on low-resolution
electron microscopy images of the Shigella needle, the monomers
that make up the needle pack in a helical fashion to give rise
to an extended cylinder with an architecture of 5.6 subunits
per turn and a 24Å helical pitch (Cordes et al., 2003). The TC
that caps the T3SA needle consists of five copies of the protein
IpaD (Picking et al., 2005; Espina et al., 2006; Epler et al., 2012),
which is consistent with a report that the Yersinia TC contains
five copies of the IpaD homolog LcrV (Mueller et al., 2005).
Under the appropriate conditions, the TC also contains IpaB
(Olive et al., 2007; Veenendaal et al., 2007; Cheung et al., 2015),
which is a hydrophobic protein that assumes different structural
states that relate to its multiple roles in Shigella virulence (see
below).
FIGURE 1 | A schematic of the type III secretion apparatus (T3SA) is
shown. For Shigella, the cytoplasmic sorting platform contains multiple copies
of Spa33, MxiN, and possibly MxiK. The platform is proposed to house the
Spa47 ATPase and the Spa13 stalk that links it to the major export protein
MxiA. Within the inner membrane are MxiJ and MxiG, the latter of which may
promote interaction with the proteins of the sorting platform (e.g., Spa33).
Located within the outer membrane and spanning the periplasm, respectively,
are the OM ring protein MxiD and the inner rod protein MxiI. External to the
outer membrane and spanning the O antigen layer of the LPS is the needle
which is composed of many copies of MxiH which are assembled in a helical
manner to provide a conduit from the basal body to the extracellular milieu.
Capping the needle and controlling type III secretion in response to
extracellular signals is the tip complex (TC). It is proposed that the TC of newly
formed needles is comprised of five copies of IpaD, however, a TC containing
four copies of IpaD and one of IpaB has been suggested. Following maturation
(as caused by exposure to bile salts, for example), IpaB is recruited to the
T3SA needle tip and it is from this position that it contributes to control of type
III secretion by sensing contact with a host cell either through the recognition
of receptor proteins or insertion into the host cell membrane. In the absence of
IpaC, IpaB is still capable of inserting into target cell membranes to form what
may be described as the pre-translocon pore. In the presence of IpaC, IpaB
penetration of the host membrane promotes full secretion induction and
formation of the translocon pore through which effector proteins pass.
The Role of the Needle Tip Complex in
Regulating Secretion
Three Shigella T3SA proteins that contribute to secretion control
from an extracellular location are MxiH (needle monomer;
Kenjale et al., 2005), IpaD (the nascent needle TC; Picking et al.,
2005; Olive et al., 2007; Stensrud et al., 2008; Roehrich et al.,
2013) and IpaB (part of the mature TC following exposure to bile
salts; Olive et al., 2007; Epler et al., 2009; Roehrich et al., 2010).
A mxiH null mutation eliminates type III secretion due to loss
of the needle, however, an ipaD or ipaB null mutation results in
uncontrolled hypersecretion (Ménard et al., 1993, 1994a). This
suggests a central role for each in sensing the extracellular signals
responsible for secretion induction. The functional roles of IpaD
and IpaB in sensing the environment, in combination with their
localization at the Shigella surface, suggests they can be used as
antigens to induce a protective/neutralizing immune response
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(Martinez-Becerra et al., 2012, 2013a). This is consistent with
the observation that antibodies against the Yersinia TC protein
LcrV (Mueller et al., 2005) neutralize its function of delivering
Yop proteins (Cowan et al., 2005). In fact, IpaD and IpaB are
now both being successfully explored as targets for generating
a serotype-independent subunit vaccine to prevent shigellosis
(Martinez-Becerra et al., 2012, 2013b).
As mentioned, Shigella IpaD has been shown to be important
for controlling type III secretion and this appears to also be true
for its Salmonella homolog SipD (Ménard et al., 1993; Kaniga
et al., 1995; Picking et al., 2005; Veenendaal et al., 2007; Roehrich
et al., 2013). This may also be the case for LcrV from Yersinia
since it provides the scaffold for Yop translocon formation (Broz
et al., 2007). Because IpaB is part of the TC under certain
conditions, it is probably from this position that it contributes
to secretion control (Olive et al., 2007; Veenendaal et al., 2007;
Shen et al., 2010; Cheung et al., 2015). Since IpaB is known to be
a cholesterol binding protein (Lafont et al., 2002; Hayward et al.,
2005; Epler et al., 2009) and binds proteins associated with lipid
rafts such as integrins and CD44 (Watarai et al., 1996; Skoudy
et al., 2000), there is consensus that IpaB recognizes host cell
contact as part of the T3SA needle TC. IpaB is thus important
in controlling type III secretion as part of the T3SA needle TC
(Epler et al., 2009) and it is possible that its C terminus is directly
involved in this process (Roehrich et al., 2010).
Cytoplasmic IpaB Forms a Heterodimer
with IpgC
IpaB contains notable hydrophobicity which renders it unstable
when expressed in the absence of its chaperone IpgC (Menard
et al., 1994b; Birket et al., 2007). IpgC binds to a defined
region near the IpaB N terminus (between residues 11 and
76) and has been proposed to bind a region near the IpaB C
terminus (Page et al., 2001; Birket et al., 2007; Lunelli et al., 2009;
Lokareddy et al., 2010; Adam et al., 2012). IpgC binding leads
to the formation of a heterodimer in the bacterial cytoplasm
(Birket et al., 2007; Adam et al., 2012), though a heterotrimer
containing two IpgC and one IpaB has been proposed (Lokareddy
et al., 2010). Chaperone association stabilizes IpaB and renders
it soluble in aqueous solution (Birket et al., 2007). Removal
of IpgC probably occurs as the IpaB/IpgC complex docks at
the cytoplasmic sorting platform of the Shigella T3SA (Lara-
Tejero et al., 2011; Hu et al., 2015). Released IpgC is retained in
the bacterial cytoplasm where it forms IpgC homodimers that
associate with MxiE to become an active transcription factor
to promote late T3SS effector expression (Mavris et al., 2002;
Pilonieta and Munson, 2008; Bongrand et al., 2012). Removal of
the chaperone for recombinant IpaB and IpgC co-expressed in
E. coli can be accomplished using mild detergents (Dickenson
et al., 2013b). Interestingly, different detergents influence the
released IpaB in different ways. The effect of detergents on the
secondary, tertiary and quaternary structures (and themembrane
active behavior) of IpaB is discussed below.
IpaB the Translocator
Beyond the needle and TC of the ShigellaT3SA lies the translocon
that forms in the host cell membrane following bacterial contact
(Blocker et al., 1999; Veenendaal et al., 2007). Translocon
formation occurs concomitant with full induction of type III
secretion (Lafont et al., 2002; Epler et al., 2009). Bile salts promote
recruitment of IpaB into the T3SA needle TC, apparently as a
result of direct binding of bile salts by IpaD at the needle tip
(Olive et al., 2007; Stensrud et al., 2008). The defining point at
which the TC ends and the translocon begins is not entirely
clear. Some groups have observed the translocon proteins IpaB
and IpaC as part of the mature TC prior to host cell contact
(Veenendaal et al., 2007), however, the conditions to which the
bacteria are exposed may have a role in dictating the observed TC
composition (Olive et al., 2007; Stensrud et al., 2008; Epler et al.,
2009; Cheung et al., 2015). A number of studies on Shigella have
not found IpaB or IpaC as part of the TC (Espina et al., 2006; Sani
et al., 2007) and thus far no translocator protein has been found
to be part of any other T3SA needle TC complex (e.g., in Yersinia;
Mueller et al., 2005).
Once formed, the translocon pore is comprised of IpaB and
IpaC. Its properties have been analyzed following insertion into
erythrocytes using contact-mediated hemolysis (Blocker et al.,
1999; Picking et al., 2005; Veenendaal et al., 2007). In the absence
of IpaD or IpaB, translocons do not form and Shigella is rendered
completely unable to lyse erythrocytes (Blocker et al., 1999;
Picking et al., 2005). In the absence of IpaC, however, Shigella
remains ∼10% hemolytic, suggesting that IpaB is inserted into
erythrocyte membranes in IpaC’s absence where it is still able to
form a pore and/or causemembrane damage (Blocker et al., 1999;
Adam et al., 2014).
IpaB’s In vitro Pore-Forming Ability
As part of the translocon, IpaB and IpaC both contribute to
pore formation, however, IpaB is also capable of forming pores
when prepared as a purified recombinant protein (Senerovic
et al., 2012; Dickenson et al., 2013b). Recombinant IpaB co-
expressed with its chaperone IpgC is readily separated from
its chaperone using detergents (Menard et al., 1994b; Hume
et al., 2003; Birket et al., 2007; Senerovic et al., 2012; Dickenson
et al., 2013b), however, the detergent used has a significant
impact on IpaB’s behavior in solution. When prepared in
n-octyl-polyoxyethylene (OPOE), IpaB forms stable tetramers,
but when prepared in lauryldimethylamine oxide (LDAO) it
forms monomers (Dickenson et al., 2013b). While OPOE has
a range of molecular sizes due to its chemical heterogeneity
(Dickenson et al., 2013b), LDAO is a single Zwitterionic molecule
[H25C12-N(CH3)2O] that has a critical micelle concentration
(CMC) about tenfold lower than OPOE. Perhaps related to their
different CMCs, IpaB can be maintained at a high concentration
in 0.05% LDAO as opposed to 0.5% OPOE (Dickenson et al.,
2013b). Reducing either detergent to below their relative CMCs
results in IpaB aggregation.
Both tetrameric and monomeric IpaB retain a strongly α-
helical secondary structure (Dickenson et al., 2013b), however,
it appears that IpaB prepared in LDAO assumes a structure
that is somewhat characteristic of a molten globular state
(Chen et al., 2015). Interestingly, while IpaB prepared in either
of these detergents associates with phospholipid membranes,
only tetrameric IpaB causes the size-dependent release of
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 3 February 2016 | Volume 6 | Article 12
Picking and Picking IpaB from Shigella
FIGURE 2 | While a high-resolution structure of full-length IpaB (580 amino acids) is not yet available, an understanding of its functional organization
is taking shape. Two major chaperone-binding domains (CBD’s) have been located between residues 11 and 76 near the IpaB N terminus. Additional regions that
may be involved in mediating IpaB interactions with itself and possibly other proteins are located near the C terminus. The one region for which there is a high
resolution structure lies between residues 120 and 224 which forms a highly elongated coiled-coil. A remarkably similar structure spans residues 80–226 in SipB, the
Salmonella homolog of IpaB, and similar structures are predicted within the homologs EspD (Enteropathogenic E. coli) and YopB (Yersinia spp.). This coiled-coil may
have a role in anchoring IpaB to IpaD at the T3SA needle tip which would allow IpaB to position its hydrophobic domain for contact with a host cell, not unlike what
occurs for membrane-interacting colicins. A large hydrophobic domain lies mostly within the C-terminal half of IpaB and it contains a predicted α-helical hairpin similar
to what has been observed in some membrane-interacting colicins. The region involved in IpaB’s ability to associate with and activate caspase 1 is reported to also lie
within this region (between residue 316 and 401).
fluorescent molecules trapped in liposomes (Dickenson et al.,
2013b). This suggests that IpaB prepared in OPOE has
pore-like properties following insertion into phospholipid
membranes.
IpaB has also been described as forming alternative oligomeric
forms depending upon the detergent composition of the solution
(Hume et al., 2003; Senerovic et al., 2012). When prepared
in OPOE which is subsequently removed, IpaB forms trimers
that efficiently bind cholesterol and insert into cultured cells
in a cholesterol-dependent manner (Hume et al., 2003). This
occurs without disruption of the cell membrane, however, this
complex also promotes the fusion of liposomes when tested
in vitro. When IpaB is prepared in LDAO and then the detergent
concentration reduced to below its CMC, it oligomerizes in
some cases with the resulting oligomers being considerably larger
than the tetramers observed in OPOE (Senerovic et al., 2012)
or the timers seen after removal of OPOE (Hume et al., 2003).
In this case, the oligomers are decamers that can form cation
channels in cultured macrophages that are triggered to undergo
caspase-mediated pyroptosis (Senerovic et al., 2012). How this
relates to possible IpaB effector functions is addressed in the next
section.
Unlike the above decameric complexes, IpaB tetramers
formed in OPOE are more like what might be expected in
translocon pore formation since the approximate cutoff of
molecules released from liposomes in their presence is in the
range of 3–5 nm, which is similar to the 2.5 nm translocon pore
diameter previously described (Blocker et al., 1999). Following
crystal structure determination for a large segment of the IpaB N
terminus (Barta et al., 2012) and determination that this region
associates with IpaD (Dickenson et al., 2013a), it is possible that
the tetramer represents IpaB as it exists within the T3SA needle
TC. The N-terminal region forms a coiled-coil that may anchor
the tetramer to IpaD at the needle tip which would allow insertion
of IpaB into the host cell membrane via its exposed hydrophobic
domain (Barta et al., 2012; Adam et al., 2014). This would form
the progenitor of the translocon pore (pre-translocon pore) and
be consistent with the structural similarity seen between the
IpaB (and Salmonella SipB) N-terminal coiled-coil and the tether
portion of bacterial colicins (Barta et al., 2012). It would also
be consistent with the cholesterol-binding (Lafont et al., 2002;
Hayward et al., 2005) pore-forming toxins (Senerovic et al., 2012)
to which IpaB has been compared (High et al., 1992).
IpaB Effector Function
IpaB is typically referred to as a Shigella T3SS translocator
protein, however, it has additional roles in Shigella pathogenesis.
IpaB has been described as an integral component of the
T3SA needle TC, whether as a stable component or a transient
component during transition from quiescent to mature T3SA. As
a TC component, IpaB is likely to recognize the host cell surface,
either through lipid raft-associated protein receptors or through
lipids (cholesterol or sphingolipids) to promote its own insertion
via an internal hydrophobic domain. An additional important
function identified early in the study of IpaB was its ability to
induce apoptosis (revised later to pyroptosis) inmacrophages due
to activation of caspase 1 (Zychlinsky et al., 1992, 1994). This
occurs through a direct interaction of IpaB with caspase 1 (Hilbi
et al., 1998; Guichon et al., 2001) which results in the release
of IL-1β as a precursor to the inflammation responsible for the
pathology of shigellosis (Guichon et al., 2001). As noted above, in
parallel with caspase activation IpaB may form cation channels
that further lead to macrophage pyroptosis via caspase-mediated
release of IL-1β (Senerovic et al., 2012). Its ability to influence
cholesterol relocation within host cells has also been shown to
adversely affect Golgi function (Mounier et al., 2012). Thus, in
addition to its roles in sequestering the transcription activator
IpgC prior to secretion from the Shigella cytoplasm, contributing
to the structure of the mature T3SA needle TC, and forming the
translocon pore, IpaB also has a role in promoting macrophage
killing as a T3SS effector. The macrophage killing then promotes
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the release of Shigella from macrophages beneath the colonic
epithelium to allow Shigella invasion of colonic epithelial cells.
CONCLUDING REMARKS
IpaB is clearly a remarkable protein having multiple roles during
the course of Shigella infection. Figure 2 outlines some of what
is known of the functional organization of IpaB. Some of these
roles may be directly related to the different structural states
IpaB can assume in vitro. Further high-resolution structural
information will be needed for purified recombinant IpaB and in
situ (TC-localized) IpaB before this will be known with certainty.
Nevertheless, because of its central role as a virulence factor
coupled with its surface exposure (along with IpaD) at the surface
of Shigella, IpaB is a potential target for prevention of shigellosis.
Thus, while the multifunctional capacity of IpaB provides an
excellent target for understanding Shigella virulence, it is also
being used for developing strategies to prevent shigellosis.
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